迈向共识DSC-MRI协议:验证低翻转角单剂量方案作为脑肿瘤参考标准
这项3中心研究纳入84例脑病变患者(43例符合标准),比较低翻转角无预载DSC-MRI(30°/P-/C+)与参考标准(60°/P+/C+)的标准化相对CBV,发现30°/P-/C+与参考标准最接近(一致性相关系数0.96),两者在10%水平统计学等效,提示低翻转角无预载加渗漏校正可作为单剂量替代方案。
要点
- 30°/P-/C+与60°/P+/C+的标准化相对CBV均值最接近(P=0.61),一致性相关系数最高(0.96)。
- 30°/P-/C+与60°/P+/C+的标准化相对CBV在10%水平统计学等效。
- 30°/P-与60°/P+的时间信噪比无显著差异(P=0.06)。
核心结论
- 低翻转角、无预载DSC-MR成像结合渗漏校正所得肿瘤相对CBV,是较高剂量参考标准的一种有吸引力的单剂量替代方案。
研究设计与样本
- 3中心研究,84例脑病变患者入组,43例符合纳入标准;3T,单剂量钆布醇,梯度回波-EPI,TE=20-35毫秒,TR=1.2-1.63秒;每例患者行两次DSC-MR成像,翻转角30°-35°无预载(P-)为后续翻转角60°提供预载(P+);生成归一化相对CBV和标准化相对CBV图,包括渗漏校正(C+)和无渗漏校正(C-)。
诊断标准与关键数值
- 与60°/P+/C+相比,30°/P-/C+的标准化相对CBV均值最接近(P=0.61),Lin一致性相关系数最高(0.96),Bland-Altman偏倚最低(μ=1.89);30°/P-/C-为P=0.02、一致性相关系数0.59、μ=14.6;60°/P+/C-为P=0.03、一致性相关系数0.88、μ=-10.1;各协议间对比噪声比无统计学差异;30°/P-/C+或60°/P+/C+的归一化相对CBV和标准化相对CBV在10%水平统计学等效;30°/P-与60°/P+的时间信噪比无显著差异(P=0.06)。
临床应用与阅片要点
- 作者认为,低翻转角、无预载DSC-MR成像结合渗漏校正所得肿瘤相对CBV是单剂量替代较高剂量参考标准的有吸引力方案。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: DSC-MR imaging using preload, intermediate (60°) flip angle and postprocessing leakage correction has gained traction as a standard methodology. Simulations suggest that DSC-MR imaging with flip angle = 30° and no preload yields relative CBV practically equivalent to the reference standard. This study tested this hypothesis in vivo.
MATERIALS AND METHODS: Eighty-four patients with brain lesions were enrolled in this 3-institution study. Forty-three patients satisfied the inclusion criteria. DSC-MR imaging (3T, single-dose gadobutrol, gradient recalled-echo-EPI, TE = 20-35 ms, TR = 1.2-1.63 seconds) was performed twice for each patient, with flip angle = 30°-35° and no preload (P-), which provided preload (P+) for the subsequent intermediate flip angle = 60°. Normalized relative CBV and standardized relative CBV maps were generated, including postprocessing with contrast agent leakage correction (C+) and without (C-) contrast agent leakage correction. Contrast-enhancing lesion volume, mean relative CBV, and contrast-to-noise ratio obtained with 30°/P-/C-, 30°/P-/C+, and 60°/P+/C- were compared with 60°/P+/C+ using the Lin concordance correlation coefficient and Bland-Altman analysis. Equivalence between the 30°/P-/C+ and 60°/P+/C+ protocols and the temporal SNR for the 30°/P- and 60°/P+ DSC-MR imaging data was also determined.
RESULTS: Compared with 60°/P+/C+, 30°/P-/C+ had closest mean standardized relative CBV (P = .61), highest Lin concordance correlation coefficient (0.96), and lowest Bland-Altman bias (μ = 1.89), compared with 30°/P-/C- (P = .02, Lin concordance correlation coefficient = 0.59, μ = 14.6) and 60°/P+/C- (P = .03, Lin concordance correlation coefficient = 0.88, μ = -10.1) with no statistical difference in contrast-to-noise ratios across protocols. The normalized relative CBV and standardized relative CBV were statistically equivalent at the 10% level using either the 30°/P-/C+ or 60°/P+/C+ protocols. Temporal SNR was not significantly different for 30°/P- and 60°/P+ (P = .06).
CONCLUSIONS: Tumor relative CBV derived from low-flip angle, no-preload DSC-MR imaging with leakage correction is an attractive single-dose alternative to the higher dose reference standard.
引用
- Schmainda KM, Prah MA, Hu LS, et al. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors. AJNR Am J Neuroradiol. 2019. PMID: 30923088. doi:10.3174/ajnr.A6015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。